It was previously reported that the combined blockade of IL‐6 and CTLA‐4 improved the survival of tumour‐bearing mice by reducing infiltration of PD‐1+CD8+ T cells and M2 macrophages in the tumour microenvironment (TME).4 Here, IL6 is linked to neoplasm.